Portela

Authorised

This medicine is authorised for use in the European Union

relfovetmab

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Product details

• Name of medicine:
  Portela
• Active substance:
  relfovetmab
• International non-proprietary name (INN) or common name:
  relfovetmab

Pharmacotherapeutic group

• Nervous system
• Other analgesics and antipyretics

Authorisation details

• EMA product number:
  EMEA/V/C/005890

Assessment history

Initial marketing authorisation documents

CVMP summary of positive opinion for Portela

Adopted Reference Number: EMA/CVMP/285092/2025